Literature DB >> 26796413

High Risk Human Papillomavirus Infection of the Foreskin in Asymptomatic Men and Patients with Phimosis.

Larissa A Afonso1, Thaissa I Cordeiro1, Fernanda N Carestiato1, Antonio Augusto Ornellas2, Gilda Alves3, Sílvia M B Cavalcanti1.   

Abstract

PURPOSE: There has been increasing interest in understanding the natural history of HPV and the diseases that it causes in men. HPV infection is strongly associated with penile cancer, lack of neonatal circumcision and phimosis. We investigated the incidence of HPV infection in asymptomatic men and patients with phimosis.
MATERIALS AND METHODS: We assessed 110 asymptomatic men and 30 patients who underwent circumcision due to phimosis. DNA was extracted from swabbed samples collected from asymptomatic men and from foreskin samples collected at circumcision. Polymerase chain reaction using consensus primers for detecting HPV-MY09/11 was performed to detect generic HPV DNA. HPV genotyping was done by polymerase chain reaction amplification with primers for the E6 gene DNA sequences HPV6, HPV11, HPV16, HPV18, HPV31, HPV33, HPV35, HPV45 and HPV58.
RESULTS: HPV was present in 46.66% of patients with phimosis, of whom 50% had high risk HPV genotypes. Of asymptomatic cases 16.36% were HPV positive but only 1 sample showed high risk HPV. We detected a significantly high rate of HPV genital infection in patients presenting with phimosis compared with asymptomatic men (p = 0.00167). The prevalence of high risk HPV genotypes in patients with phimosis was also statistically significant (p = 0.0004).
CONCLUSIONS: We found a robust association between phimosis and the genital HPV prevalence in men and a significant frequency of high risk HPV. Other studies are needed to investigate the occurrence of factors that can increase the incidence of penile carcinoma and determine its impact on female genital infection in cervical cancer.
Copyright © 2016 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  circumcision, male; human papillomavirus DNA tests; infection; penis; phimosis

Mesh:

Year:  2016        PMID: 26796413     DOI: 10.1016/j.juro.2015.12.096

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Should routine neonatal circumcision be a police to prevent penile cancer? | Opinion: Yes.

Authors:  Antonio Augusto Ornellas; Paulo Ornellas
Journal:  Int Braz J Urol       Date:  2017 Jan-Feb       Impact factor: 1.541

2.  Human papillomavirus (HPV) genotype distribution in penile carcinoma: Association with clinic pathological factors.

Authors:  Lyriane Apolinário de Araújo; Adriano Augusto Peclat De Paula; Hellen da Silva Cintra de Paula; Jessica Enocêncio Porto Ramos; Brunna Rodrigues de Oliveira; Keila Patrícia Almeida De Carvalho; Rafael Alves Guimarães; Rita de Cássia Gonçalves de Alencar; Eliza Carla Barroso Duarte; Silvia Helena Rabelo Santos; Vera Aparecida Saddi; Megmar Aparecida Dos Santos Carneiro
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

3.  Evidence-based circumcision policy for Australia.

Authors:  Brian J Morris; Athos Katelaris; Norman J Blumenthal; Mohamed Hajoona; Adrian C Sheen; Leslie Schrieber; Eugenie R Lumbers; Alex D Wodak; Phillip Katelaris
Journal:  J Mens Health       Date:  2022-05-30       Impact factor: 0.789

4.  Critical evaluation of arguments opposing male circumcision: A systematic review.

Authors:  Brian J Morris; Stephen Moreton; John N Krieger
Journal:  J Evid Based Med       Date:  2019-09-08

5.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.